A large meta-analysis by Samarendra et al., which included 5807 patients with different cancer types, including breast cancer, revealed that SDF-1α expression may become a cancer biomarker and indicate patients’ prognoses. This evidence concerns the gene CXCL12 and breast carcinoma.